PT2073008E - Métodos de imunoensaio melhorados - Google Patents

Métodos de imunoensaio melhorados Download PDF

Info

Publication number
PT2073008E
PT2073008E PT09004778T PT09004778T PT2073008E PT 2073008 E PT2073008 E PT 2073008E PT 09004778 T PT09004778 T PT 09004778T PT 09004778 T PT09004778 T PT 09004778T PT 2073008 E PT2073008 E PT 2073008E
Authority
PT
Portugal
Prior art keywords
immunoassay methods
improved immunoassay
antibody
improved
relats
Prior art date
Application number
PT09004778T
Other languages
English (en)
Inventor
John Forsyth Russell Robertson
Tony Barnes
Caroline Chapman
Andrea Murray
Original Assignee
Oncimmune Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncimmune Ltd filed Critical Oncimmune Ltd
Publication of PT2073008E publication Critical patent/PT2073008E/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT09004778T 2005-05-27 2006-05-26 Métodos de imunoensaio melhorados PT2073008E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68542205P 2005-05-27 2005-05-27
GB0510943A GB2426581A (en) 2005-05-27 2005-05-27 Immunoassay methods

Publications (1)

Publication Number Publication Date
PT2073008E true PT2073008E (pt) 2012-06-18

Family

ID=34834805

Family Applications (2)

Application Number Title Priority Date Filing Date
PT09004778T PT2073008E (pt) 2005-05-27 2006-05-26 Métodos de imunoensaio melhorados
PT101807568T PT2275815E (pt) 2005-05-27 2006-05-26 Métodos de imunoensaio melhorados

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT101807568T PT2275815E (pt) 2005-05-27 2006-05-26 Métodos de imunoensaio melhorados

Country Status (19)

Country Link
US (1) US8722339B2 (pt)
EP (3) EP1889059B1 (pt)
JP (1) JP4876127B2 (pt)
KR (1) KR101400986B1 (pt)
CN (2) CN101203756B (pt)
AT (2) ATE436018T1 (pt)
AU (1) AU2006250923B2 (pt)
CA (1) CA2609793C (pt)
DE (1) DE602006007703D1 (pt)
DK (3) DK1889059T3 (pt)
ES (3) ES2384935T3 (pt)
GB (1) GB2426581A (pt)
MX (1) MX2007014815A (pt)
NO (1) NO339224B1 (pt)
PL (2) PL2073008T3 (pt)
PT (2) PT2073008E (pt)
RU (1) RU2416095C2 (pt)
SI (1) SI2073008T1 (pt)
WO (1) WO2006126008A2 (pt)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6136311A (en) 1996-05-06 2000-10-24 Cornell Research Foundation, Inc. Treatment and diagnosis of cancer
GB9810040D0 (en) 1998-05-11 1998-07-08 Univ Nottingham Blood borne tumour markers
GB9827228D0 (en) * 1998-12-10 1999-02-03 Univ Nottingham Cancer detection method and reagents
US20030232399A1 (en) * 2000-06-14 2003-12-18 Robertson John Forsyth Russell Cancer detection methods and reagents
GB2424273B (en) * 2002-11-14 2007-06-27 Univ Nottingham Method for preparing tumour marker protein
US7858323B2 (en) 2004-06-09 2010-12-28 The Regents Of The University Of Michigan Phage microarray profiling of the humoral response to disease
RU2636532C2 (ru) 2005-05-27 2017-11-23 Онкиммьюн Лимитед Улучшенные способы иммуноанализа
GB2426581A (en) 2005-05-27 2006-11-29 Univ Nottingham Immunoassay methods
EP2485047B1 (en) * 2005-12-22 2016-10-26 Abbott Molecular Inc. Methods and marker combinations for screening for predisposition to lung cancer
US9347945B2 (en) * 2005-12-22 2016-05-24 Abbott Molecular Inc. Methods and marker combinations for screening for predisposition to lung cancer
EP1996716B1 (en) 2006-03-20 2011-05-11 The Regents of the University of California Engineered anti-prostate stem cell antigen (psca) antibodies for cancer targeting
CN101632020B (zh) 2006-09-13 2013-11-27 昂西免疫有限公司 改进的免疫测定方法
AU2007297310B2 (en) * 2006-09-13 2013-11-07 Oncimmune Limited Improved immunoassay methods
WO2008042508A1 (en) * 2006-10-03 2008-04-10 University Of Southern California Grp78 as a predictor of responsiveness to therapeutic agents
CA2679205A1 (en) * 2007-02-23 2008-08-28 Predictive Biosciences Corporation Clinical intervention directed diagnostic methods
WO2009032949A2 (en) 2007-09-04 2009-03-12 The Regents Of The University Of California High affinity anti-prostate stem cell antigen (psca) antibodies for cancer targeting and detection
EP3192808A1 (en) 2007-11-27 2017-07-19 The University Of British Columbia 14-3-3 antagonists for the prevention and treatment of arthritis
GB0725239D0 (en) * 2007-12-24 2008-02-06 Oncimmune Ltd Calibrator for autoantibody assay
ES2433745T3 (es) * 2008-02-21 2013-12-12 Iris International, Inc. Procedimiento para la determinación temprana de recidivas tras la terapia para el cáncer de próstata
JP5433698B2 (ja) 2008-09-19 2014-03-05 リッジビュー ダイアグノスティックス アーベー 固体生物学的物体の分析のための方法
EP2389585A2 (en) * 2009-01-22 2011-11-30 Li-Cor, Inc. Single molecule proteomics with dynamic probes
ES2712732T3 (es) 2009-02-17 2019-05-14 Cornell Res Foundation Inc Métodos y kits para el diagnóstico de cáncer y la predicción de valor terapéutico
KR101894597B1 (ko) * 2009-03-11 2018-10-04 오거렉스 라이프 사이언시스 코포레이션 관절염 상태를 특성화하는 조성물 및 방법
KR20120098992A (ko) * 2009-06-23 2012-09-06 이벤투스 디아그노스틱스 이스라엘 리미티드 암의 검출을 위한 방법 및 시스템
CN101762700A (zh) * 2009-06-24 2010-06-30 北京科美东雅生物技术有限公司 一种定量检测血液中癌胚抗原的磁性免疫层析试纸条及制备方法
EP2456458B1 (en) 2009-07-24 2018-12-26 Rhode Island Hospital Dendritic cell vaccines for asparaginyl - beta - hydroxylase expressing tumors
EP2494352B1 (en) * 2009-10-26 2020-04-08 Prometheus Biosciences, Inc. Assays for the detection of anti-tnf drugs and autoantibodies
CA2782333C (en) 2009-12-02 2019-06-04 Imaginab, Inc. J591 minibodies and cys-diabodies for targeting human prostate specific membrane antigen (psma) and methods for their use
EP3450979A3 (en) 2010-03-17 2019-04-24 The Regents of The University of Michigan Using phage epitopes to profile the immune response
CN102884434B (zh) * 2010-05-12 2015-08-19 希尔氏宠物营养品公司 用于诊断、控制和预防犬科动物炎症及减轻犬科动物炎性病况的方法
US20130310266A1 (en) * 2010-09-03 2013-11-21 Immport Therapeutics, Inc. Methods and Compositions For The Diagnosis And Treatment Of Cancer and Autoimmune Disorders
CA2814029C (en) * 2010-10-08 2017-05-09 Shanghai Kexin Biotech Co., Ltd. Moesin fragments associated with immune thrombocytopenia
EA018848B1 (ru) * 2010-10-20 2013-11-29 Вадим Юльевич ШАНИН Иммунологически активное вещество, способ его получения, биозонд на его основе и способ диагностики состояния здоровья с применением биозонда, фармацевтическая композиция и способ лечения с использованием фармацевтической композиции
CN102125698A (zh) * 2010-11-29 2011-07-20 昆明理工大学 具有正常免疫功能的小鼠移植肿瘤模型的建立方法
EP2726867B1 (en) * 2011-07-01 2016-04-06 Inova Diagnostics, Inc. Method for increasing specificity of diagnostic tests for autoimmune diseases
PL2768851T3 (pl) 2011-10-21 2018-05-30 Augurex Life Sciences Corp. Antygeny pochodzące z cytrulinowanego białka 14-3-3 oraz ich zastosowania w diagnozie reumatoidalnego zapalenia stawów
CN102590530B (zh) * 2012-03-02 2014-06-25 常晓天 Krt84自我免疫抗体作为诊断、检测类风湿性关节炎的诊断标记物的应用
CN104428674A (zh) * 2012-04-24 2015-03-18 思研（Sri）国际顾问与咨询公司 前列腺癌和sar-cov的人血清生物标记物
CA2894538A1 (en) * 2013-01-31 2014-08-07 Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Ari Autoantibody signature for the early detection of ovarian cancer
CN103604923B (zh) * 2013-10-22 2015-05-13 卫生部北京医院 检测抗甲状腺过氧化物酶和甲状腺球蛋白的天然双特异性抗体的试剂盒
DK3102600T3 (en) * 2014-02-05 2019-04-01 Fujirebio Diagnostics Ab COMPOSITION AND PROCEDURE FOR DETECTIVE DEPARTURAL NEOPLASTIC DISEASE
GB201411060D0 (en) * 2014-06-20 2014-08-06 Oncimmune Ltd Improved immunoassay method
CN104356226B (zh) * 2014-11-04 2017-03-29 青岛海兰深生物科技有限公司 一种检测血浆免疫标志物‑vegfr1自身抗体的抗原多肽及应用
SG10201913625XA (en) 2015-08-07 2020-03-30 Imaginab Inc Antigen binding constructs to target molecules
EP3502701A3 (en) * 2015-12-11 2019-07-10 Sanford Health Reagents and methods for monitoring breast cancer therapy
CN106053812B (zh) * 2016-06-29 2017-12-08 厦门生迪生物技术有限公司 一种用于肝癌早期筛查和诊断的多种自身抗体联合检测elisa试剂盒
JP6334017B1 (ja) * 2017-01-25 2018-05-30 ファナック株式会社 誘導電動機の制御装置
US11266745B2 (en) 2017-02-08 2022-03-08 Imaginab, Inc. Extension sequences for diabodies
CN111108388A (zh) * 2017-06-23 2020-05-05 昂西免疫德国有限公司 用于治疗癌症的免疫肿瘤学
WO2019152498A1 (en) * 2018-02-01 2019-08-08 Sedia Biosciences Corporation A rapid quantitative assay to assess duration of infection
EP4182693A2 (en) 2020-07-14 2023-05-24 Oncimmune Limited Use of antigen combination for detecting autoantibodies in lung cancer
GB2600701A (en) 2020-11-04 2022-05-11 Oncimmune Ltd Antibody assay
CN112345755B (zh) * 2020-09-23 2023-06-16 杭州凯保罗生物科技有限公司 乳腺癌的生物标志物及其应用
GB2622246A (en) 2022-09-08 2024-03-13 Oncimmune Germany Gmbh Antibody assay

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ211453A (en) * 1984-03-22 1989-01-06 Biotechnology Research Enterpr Aryl azides, their preparation and use in the detection, localisation and isolation of polynucleotides
ATE77700T1 (de) 1986-03-10 1992-07-15 Imre Corp Immunkomplextestverfahren.
US4925788A (en) * 1986-10-24 1990-05-15 Immunicon Corporation Immunoassay system and procedure based on precipitin-like interaction between immune complex and Clq or other non-immunospecific factor
AU2253688A (en) 1987-07-24 1989-03-01 Xoma Corporation Methods for breast cancer detection
US4937185A (en) * 1987-07-31 1990-06-26 The Ohio State University Research Foundation Detection of circulating antibodies to a cancer marker protein
US7282345B1 (en) * 1989-08-04 2007-10-16 Schering Ag C-erbB-2 external domain: GP75
US5157020A (en) * 1990-05-24 1992-10-20 Research Corporation Tech., Inc. Synthetic senescent cell antigen
DK9091D0 (da) 1991-01-18 1991-01-18 Novo Nordisk As Fremgangsmaade til fremstilling af antistoffer
DE4120412C1 (pt) * 1991-06-20 1993-01-07 Henning Berlin Gmbh Chemie- Und Pharmawerk, 1000 Berlin, De
US6322989B1 (en) * 1991-11-25 2001-11-27 Yoreh Biotechnologies, Ltd. Whole blood/mitogen assay for the early detection of a subject with ovarian or breast cancer and kit
US6280962B1 (en) * 1991-11-25 2001-08-28 Yoreh Biotechnologies Ltd. Whole blood/mitogen assay for the early detection of a subject with cancer and kit
PT1024191E (pt) 1991-12-02 2008-12-22 Medical Res Council Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos
WO1993021529A1 (en) 1992-04-14 1993-10-28 Duke University Method of detecting tumors containing complexes of p53 and hsp70
US5801005A (en) * 1993-03-17 1998-09-01 University Of Washington Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated
US5763164A (en) * 1993-04-16 1998-06-09 Northwestern University Immunogenic cancer proteins and peptides and methods of use
US5747268A (en) * 1993-04-22 1998-05-05 Dade International Inc. Tumor marker control
CN1097252A (zh) * 1993-07-03 1995-01-11 首钢总公司 多元同步标记分析法
US5744144A (en) * 1993-07-30 1998-04-28 University Of Pittsburgh University Patent Committee Policy And Procedures Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof
US5721105A (en) * 1994-02-20 1998-02-24 B.R.A.H.M.S. Diagnostica Gmbh Method for the immunological determination of proteins and kit for carrying out the method
JPH07294530A (ja) * 1994-04-20 1995-11-10 Nippon Igaku Rinshiyou Kensa Kenkyusho:Kk 病原体に対する体液中の抗体検出法
CA2148971A1 (en) 1994-05-26 1995-11-27 Izak Bahar Calibrator matrix
WO1996000084A1 (en) 1994-06-24 1996-01-04 Torchilin Vladimir P Use of autoantibodies for tumor therapy and prophylaxis
IL110464A0 (en) 1994-07-26 1994-10-21 Univ Ramot Novel proteins for the diagnosis, imaging, and therapy of human cancer
US5561049A (en) * 1994-09-21 1996-10-01 Behringwerke Ag Method for detecting antibodies
US5876728A (en) * 1995-02-15 1999-03-02 Howard David Kass Natural composition extracted from plants used in the treatment of cancer
AUPN568095A0 (en) 1995-09-27 1995-10-26 Austin Research Institute, The Anti-Galalpha(1,3)Gal antibody binding peptides
GB9521544D0 (en) 1995-10-20 1995-12-20 Univ Dundee Activation of P53 protein and therapeutic applications thereof
JPH09189702A (ja) 1996-01-09 1997-07-22 Hitachi Chem Co Ltd 抗ムチン抗体の測定法、癌の測定法及び癌診断薬
JP2001517206A (ja) * 1996-08-16 2001-10-02 ザ ジョンズ ホプキンズ ユニヴァーシティ スクール オヴ メディシン 免疫優性な共有黒色腫抗原を発現する黒色腫細胞株およびその使用方法
CN1044092C (zh) * 1997-02-26 1999-07-14 上海医科大学 抗原－抗体－重组dna复合型疫苗
AU7713498A (en) 1997-06-03 1998-12-21 Amdl, Inc. Immunoassay for the detection of cancer
DE19805815C1 (de) * 1998-02-13 1999-11-11 Ansgar W Lohse Diagnostikum zum Erkennen der autoimmunen Hepatitis
JP4083855B2 (ja) 1998-02-16 2008-04-30 エーザイ・アール・アンド・ディー・マネジメント株式会社 肺癌予後検査方法
GB9810040D0 (en) 1998-05-11 1998-07-08 Univ Nottingham Blood borne tumour markers
AUPP349098A0 (en) 1998-05-13 1998-06-04 South Eastern Sydney Area Health Service A method of monitoring pancreatic tissue viability
ATE447713T1 (de) 1998-11-05 2009-11-15 Univ Michigan S100-proteine und -autoantikörper als serummarker für krebs
US6387639B1 (en) * 1998-11-10 2002-05-14 Sloan-Kettering Institute For Cancer Research Ma family polypeptides and anti-Ma antibodies
GB9827228D0 (en) * 1998-12-10 1999-02-03 Univ Nottingham Cancer detection method and reagents
US7807810B2 (en) * 1999-04-08 2010-10-05 The Ohio State University Research Foundation Nucleic acids encoding the major outer membrane protein of the causative agent of human granulocytic ehrlichiosis and peptides encoded thereby
US6645465B2 (en) 1999-08-06 2003-11-11 Michigan, University Of The Regents Annexin proteins and autoantibodies as serum markers for cancer
US20020064801A1 (en) * 1999-12-01 2002-05-30 Ryan Jeffrey R. Novel and practical serological assay for the clinical diagnosis of leishmaniasis
US6667160B2 (en) * 2000-03-15 2003-12-23 Kenneth D. Fine Method for diagnosing immunologic food sensitivity
US20030232399A1 (en) * 2000-06-14 2003-12-18 Robertson John Forsyth Russell Cancer detection methods and reagents
US20030138860A1 (en) * 2000-06-14 2003-07-24 Robertson John Forsyth Russell Cancer detection methods and reagents
CA2431201A1 (en) 2000-12-13 2002-08-01 Bio-Rad Laboratories, Inc. Standard diluent for multiplex assays
US7745141B2 (en) * 2001-06-21 2010-06-29 New York University Mycobacterial proteins as early antigens for serodiagnosis and vaccines
GB0128583D0 (en) * 2001-11-28 2002-01-23 Rsr Ltd Detection of autoantibodies indicative of diabetes
US20030049692A1 (en) * 2002-09-16 2003-03-13 Norman Latov Detection of anti-glycolipid antibodies by latex agglutination assay
GB2424273B (en) * 2002-11-14 2007-06-27 Univ Nottingham Method for preparing tumour marker protein
CN1547025A (zh) * 2003-12-03 2004-11-17 刘春杰 高灵敏度酶联免疫分析检测试剂盒
JP2005352771A (ja) * 2004-06-10 2005-12-22 Hitachi Software Eng Co Ltd 発現プロファイルによるパターン認識システム
US20060141547A1 (en) * 2004-11-16 2006-06-29 Das Hasi R Novel diagnostic marker, a diagnostic kit and a method for diagnosis of rheumatoid arthritis
GB2426581A (en) 2005-05-27 2006-11-29 Univ Nottingham Immunoassay methods
EP1789435B1 (en) * 2005-09-12 2010-02-24 Industry Foundation of Chonnam National University A method for production of mature natural killer cell
TWI304443B (en) * 2005-12-30 2008-12-21 Nat Health Research Institutes Alpha-enolase specific antibody and method of use
CN101632020B (zh) * 2006-09-13 2013-11-27 昂西免疫有限公司 改进的免疫测定方法
AU2007297310B2 (en) 2006-09-13 2013-11-07 Oncimmune Limited Improved immunoassay methods
GB0725239D0 (en) * 2007-12-24 2008-02-06 Oncimmune Ltd Calibrator for autoantibody assay

Also Published As

Publication number Publication date
EP2073008B1 (en) 2012-04-18
RU2416095C2 (ru) 2011-04-10
CA2609793C (en) 2018-05-22
GB2426581A (en) 2006-11-29
EP2275815A2 (en) 2011-01-19
EP1889059A2 (en) 2008-02-20
EP2275815A3 (en) 2011-02-02
ES2328171T3 (es) 2009-11-10
RU2007149281A (ru) 2009-07-10
NO20076656L (no) 2008-02-26
PL1889059T3 (pl) 2009-12-31
WO2006126008A2 (en) 2006-11-30
SI2073008T1 (sl) 2012-08-31
US8722339B2 (en) 2014-05-13
DK1889059T3 (da) 2009-11-02
DK2073008T3 (da) 2012-06-04
KR101400986B1 (ko) 2014-05-28
DE602006007703D1 (de) 2009-08-20
PT2275815E (pt) 2014-07-10
GB0510943D0 (en) 2005-07-06
CN101203756A (zh) 2008-06-18
JP4876127B2 (ja) 2012-02-15
CN102749447B (zh) 2015-05-13
CN101203756B (zh) 2016-03-09
WO2006126008A3 (en) 2007-03-29
CN102749447A (zh) 2012-10-24
NO339224B1 (no) 2016-11-21
EP2073008A1 (en) 2009-06-24
EP1889059B1 (en) 2009-07-08
ES2458105T3 (es) 2014-04-29
MX2007014815A (es) 2008-04-11
EP2275815B1 (en) 2014-04-02
ATE554386T1 (de) 2012-05-15
JP2008542703A (ja) 2008-11-27
AU2006250923B2 (en) 2012-06-07
KR20080034851A (ko) 2008-04-22
US20080305476A1 (en) 2008-12-11
ES2384935T3 (es) 2012-07-16
DK2275815T3 (da) 2014-05-12
ATE436018T1 (de) 2009-07-15
AU2006250923A1 (en) 2006-11-30
CA2609793A1 (en) 2006-11-30
PL2073008T3 (pl) 2012-09-28

Similar Documents

Publication Publication Date Title
GB0510943D0 (en) Improved immunoassay methods
BRPI0707645B8 (pt) métodos in vitro para detecção de câncer em um indivíduo e para avaliação de prognóstico de um indivíduo tendo, ou suspeito de ter, câncer ovariano
WO2008135564A3 (en) Assays
WO2006026020A3 (en) Oncofetal fibronectin as a marker for disease and other conditions and methods for detection of oncofetal fibronectin
ATE476657T1 (de) Vorhersage von letalität und detektion von schweren erkrankungen
EP3293522A3 (en) Lipidomic biomarkers for identification of high-risk coronary artery disease patients
MX2007005053A (es) Metodo para evaluar la enfermedad de alzheimer y reactivo de diagnostico.
WO2006092729A3 (en) Novel biomarkers for diagnosis and/or prognosis or prognosis of neoplasias in animals
ATE360809T1 (de) Schnelltest für biologische substanzen mittels ftir
EP1930445A4 (en) KIT AND METHOD FOR DETECTING UROTHELIAL CANCER
DE602006014581D1 (de) Turbidimetrischer immunoassay zur beurteilung von humanem cystatin c
WO2008062048A3 (en) Methods for optically detecting multiple analytes in a liquid sample with a compressible microfluidic device
NZ592819A (en) Thyroid analyte detection and measurement
ATE370414T1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
SI1977244T1 (sl) Razlikovanje med bakterijskim meningitisom in virusnim meningitisom
DE602005010548D1 (de) Verbessertes verfahren zur diagnose des akuten koronarsyndroms
CY1109461T1 (el) Βελτιωμενες μεθοδοι ανοσολογικου προσδιορισμου
EP2444812A3 (en) Improved immunoassay methods
ATE534037T1 (de) Verwendung des proteins asc als marker für brustkrebs
WO2004085669A3 (en) Identification and quantification of microbial species in a sample
EP1636587A4 (en) DIAGNOSTIC KIT FOR LIVER CIRRHOSIS COMPRISING A SPECIFIC ANTIBODY OF A HUMAN PROTO-ONCOGEN PROTEIN
CY1115323T1 (el) Βελτιωμενες μεθοδοι ανοσολογικου προσδιορισμου
DK1297342T3 (da) Metode til diagnostisk bestemmelse af Alzheimer's sygdom på basis af holo-transcobalamin II
GB0501564D0 (en) Test for prion disease
AR066491A1 (es) Equipo de enzimoinmunoensayo ( elisa) para el diagnostico de leptospirosis humana